SCM
STRO icon

Sterling Capital Management’s Sutro Biopharma STRO Stock Holding History

Sterling Capital Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.33K Buy
+281
New +$8.76K ﹤0.01% 2259
2025
Q2 		– Sell
-147
Closed -$957 – 3390
2025
Q1 		$957 Sell
147
-131
-47% -$2.06K ﹤0.01% 2835
2024
Q4 		$5.12K Buy
278
+248
+827% +$7.57K ﹤0.01% 2457
2024
Q3 		$1.04K Buy
+30
New +$1.18K ﹤0.01% 2502

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Sterling Capital Management's STRO Position: Q2 2026 in Review

Sterling Capital Management opened a new position in Sutro Biopharma (STRO) in Q2 2026: 281 shares worth $9.33K. The stake represents ﹤0.01% of the portfolio and ranks #2259 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in STRO as recently as Q1 2025.

Sterling Capital Management first reported a position in STRO in Q3 2024 and has held it in 4 quarters since. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Sterling Capital Management held 281 shares of Sutro Biopharma worth $9.33K as of Q2 2026.
  • Sutro Biopharma was a new Sterling Capital Management position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #2259 holding.
  • Sterling Capital Management first reported a position in Sutro Biopharma in Q3 2024 and has held it in 4 quarters since.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.